Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations (Q37944427)

25 August 2017

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations (English)

1 reference

amyotrophic lateral sclerosis

25 August 2017

0 references

0 references

Martin R Turner

2

0 references

author name string

Robert Bowser

series ordinal

1

1 reference

25 August 2017

Jeremy Shefner

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

11 October 2011

1 reference

25 August 2017

Nature Reviews Neurology

1 reference

25 August 2017

7

1 reference

25 August 2017

11

1 reference

25 August 2017

631-638

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.151

25 August 2017

0 references

cites work

Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Protein aggregation in motor neurone disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Recent advances in the genetics of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)--a 20-year review: can we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Onset, natural history and outcome in idiopathic adult motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Protein biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Biomarkers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Biochemical markers in CSF of ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Immunoassay using antigen-enzyme conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

CSF neurofilament protein analysis in the differential diagnosis of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Identification of potential CSF biomarkers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Multidimensional protein fractionation using ProteomeLab PF 2D for profiling amyotrophic lateral sclerosis immunity: A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Quantitative mass spectrometry in proteomics: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Proposed BioRepository platform solution for the ALS research community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Applying proteomics to the diagnosis and treatment of ALS and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

A quantitative electrophysiological study of motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Changes in motor unit populations in motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Motor unit number estimation in evaluating disease progression in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Motor unit number estimate-based rates of progression of ALS predict patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

The use of statistical MUNE in a multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Multipoint incremental motor unit number estimation as an outcome measure in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Localized bioimpedance analysis in the evaluation of neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Electrical impedance myography as a biomarker for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Distal excitability changes in motor axons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Upregulation of persistent sodium conductances in familial ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Corticobulbar tract involvement in amyotrophic lateral sclerosis. A transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Motor responses evoked by transcranial magnetic stimulation and peripheral nerve stimulation in the ulnar innervation in amyotrophic lateral sclerosis: the effect of upper and lower motor neuron lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Cortical excitability distinguishes ALS from mimic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Advances in the application of MRI to amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Frontotemporal white matter changes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

NERVE FIBRE DEGENERATION IN THE BRAIN IN AMYOTROPHIC LATERAL SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Diffusion-based tractography in neurological disorders: concepts, applications, and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

MRI-based functional neuroimaging in ALS: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Changes of resting state brain networks in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Serotonin-1A receptors in frontotemporal dementia compared with controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Cognitive impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Diffusion Tensor Imaging in Sporadic and Familial (D90A SOD1) Forms of Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

MRI predictors of long-term evolution in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Amyotrophic Lateral Sclerosis Mimic Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Motor unit territory and muscle fiber concentration in paresis due to peripheral nerve injury and anterior horn cell involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Quantitative motor assessment in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Revised statistical motor unit number estimation in the Celecoxib/ALS trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.151

Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: A six-month longitudinal study

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21989244

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reduced Interhemispheric Functional Connectivity in the Motor Cortex during Rest in Limb-Onset Amyotrophic Lateral Sclerosis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21989244

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2011.151

1 reference

Dimensions Publication ID

25 August 2017

0 references

1 reference